GALE Galenica AG

106.34USD89.60 CHF · SWX+0.90%Mkt Cap: 5.30B USDP/E: 27.74

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner …

Key Statistics

Company
Market Cap5.30B USD
Enterprise Value6.58B USD
Revenue (TTM)5.09B USD
Gross Profit1.37B USD
Net Income (TTM)214.93M USD
Revenue/Share102.01 USD
Last Price106.34 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6.6K
CountryCH
SectorHealthcare
IndustryMedical Distribution
ISINCH0360674466
Valuation
P/E (Trailing)27.74
P/E (Forward)21.08
PEG—
EV/EBITDA21.67
EV/Revenue1.29
P/S1.04
P/B3.17
EPS (TTM)3.83 USD
EPS (Forward)5.05 USD
52W Range
95.4241% of range122.24
52W High122.24 USD
52W Low95.42 USD
Profitability
Gross Margin27.94%
Oper. Margin4.77%
EBITDA Margin5.97%
Profit Margin4.38%
ROE12.22%
ROA5.49%
ROIC11.59%
ROCE9.57%
Growth
Revenue Growth7.00%
Earnings Growth-24.90%
Cash Flow & Leverage
Operating CF355.76M USD
CapEx (TTM)66.18M USD
FCF Margin3.01%
FCF Yield2.89%
Net Debt1.27B USD
Net Debt/EBITDA4.18
Net Debt/FCF8.27
Balance Sheet
Debt/Equity0.16
Current Ratio1.07
Quick Ratio0.64
Book Value/Sh33.59 USD
Cash/Share0.94 USD
Dividends
Fwd Div Rate2.97 USD
Trail. Div Rate2.97 USD
Div. Yield2.82%
5Y Avg Yield2.83%
Payout Ratio77.40%
Ex-Div DateApr 23, 2026
Pay DateApr 16, 2025
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)107.05 USD
Upside (mean)+0.7%
Target Range100.88 USD – 113.93 USD
100.88+0.7% to mean113.93
# Analysts5
Ownership
Shares Out.49.82M
Float49.76M
Insiders0.26%
Institutions53.04%
Technical
SMA 50102.12 (+4.1%)
SMA 200103.73 (+2.5%)
Beta0.23
S&P 52W Chg8.68%
Avg Vol (30d)81.25K
Avg Vol (10d)77.11K
Technical Indicators
RSI (14)55.3
MACD0.9790
MACD Signal1.2480
MACD Hist.-0.2690
BB Upper109.03 USD
BB Middle106.16 USD
BB Lower103.29 USD
BB Width5.40%
ATR (14)1.464 USD
Vol Ratio (20d)0.84x

About Galenica (SWX: GALE)

›

Galenica (SWX: GALE) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 6,623 employees.

The shares were at 89.60 CHF on 20 November 2026, up 6.7% over 52 weeks. Its 52-week range is 80.40 CHF to 103.00 CHF: the price is 13.0% below the high and 11.4% above the low.

At a market capitalisation of 4.46B CHF, it trades at 27.7 times trailing earnings and 21.1 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 19.9, a premium of 39% for GALE. It pays a dividend yielding 2.82% (it pays out 77% of its earnings), against a median of 1.38% among the dividend payers in that peer group.

Galenica reports return on equity of 12.2%, an operating margin of 4.8% and revenue up 7.0% year over year.

Its debt exceeds its cash by 1.07B CHF, a debt-to-equity ratio of 0.16. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Hold; their mean price target of 90.20 CHF is 0.7% above the current price. The next earnings report is expected on 9 March 2027.